
Sign up to save your podcasts
Or


This is the Act signed into law on August 16, 2022 by President Joe Biden. It lists the 10 drugs that Medicare will have the authority to negotiate pricing by 2026.
Eliquis affects 3.067 million Medicare patients and costs the federal government $16.482 billion dollars. This is approximately $4447.55 per patient.
Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruivia, Stelara are the remaining 9 and they round out the list of ten. Find out more about the drugs!
https://www.cms.gov/files/document/fact-sheet-medicare-selected-drug-negotiation-list-ipay-2026.pdf
What is the difference between Atrial fibrillation and Atrial High Rate Episodes? Should we anticoagulate in both cases? Find out! Host: Gloria Wu MD, Guest: Paul J. Wang, MD, Chief of Cardiac Electrophysiology, Stanford University School of Medicine. Dr Wang is the co-inventor of CryoCath.
Dr. Gloria Wu, host, and guest, Dr. Paul Wang, Professor of Medicine, Chief of Cardiac Electrophysiology, Cardiovascular Medicine Division, talk about AI and advances for patient care.
At the August 2023 meeting of the European Society of Cardiology, we discuss pregnancy and heart failure, focusing on the statistics and how it predominantly affects African Americans. Dr. Demilade Adedinshewo from the Mayo Clinic, Jacksonville, FL.
Fatima Rodriguez MD, MPH
Stanford University School of Medicine
Section Chief, Preventive Medicine, Cardiologist
From the publisher's feed